# Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia

> **NCT05419050** · PHASE2 · COMPLETED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 15 (actual)

## Conditions studied

- Fibrous Dysplasia

## Interventions

- **DRUG:** denosumab

## Key facts

- **NCT ID:** NCT05419050
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-12
- **Primary completion:** 2026-01-09
- **Final completion:** 2026-01-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05419050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05419050, "Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05419050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*